1. Home
  2. BCYC vs LXU Comparison

BCYC vs LXU Comparison

Compare BCYC & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • LXU
  • Stock Information
  • Founded
  • BCYC 2009
  • LXU 1968
  • Country
  • BCYC United Kingdom
  • LXU United States
  • Employees
  • BCYC N/A
  • LXU N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • LXU Major Chemicals
  • Sector
  • BCYC Health Care
  • LXU Industrials
  • Exchange
  • BCYC Nasdaq
  • LXU Nasdaq
  • Market Cap
  • BCYC 566.5M
  • LXU 515.4M
  • IPO Year
  • BCYC 2019
  • LXU 1969
  • Fundamental
  • Price
  • BCYC $8.22
  • LXU $7.57
  • Analyst Decision
  • BCYC Buy
  • LXU Strong Buy
  • Analyst Count
  • BCYC 10
  • LXU 4
  • Target Price
  • BCYC $25.00
  • LXU $10.00
  • AVG Volume (30 Days)
  • BCYC 333.0K
  • LXU 528.7K
  • Earning Date
  • BCYC 05-01-2025
  • LXU 04-29-2025
  • Dividend Yield
  • BCYC N/A
  • LXU N/A
  • EPS Growth
  • BCYC N/A
  • LXU N/A
  • EPS
  • BCYC N/A
  • LXU N/A
  • Revenue
  • BCYC $25,722,000.00
  • LXU $527,628,000.00
  • Revenue This Year
  • BCYC N/A
  • LXU $10.43
  • Revenue Next Year
  • BCYC $1.83
  • LXU N/A
  • P/E Ratio
  • BCYC N/A
  • LXU N/A
  • Revenue Growth
  • BCYC N/A
  • LXU N/A
  • 52 Week Low
  • BCYC $6.10
  • LXU $4.88
  • 52 Week High
  • BCYC $28.67
  • LXU $10.40
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.16
  • LXU 66.00
  • Support Level
  • BCYC $8.00
  • LXU $7.43
  • Resistance Level
  • BCYC $8.73
  • LXU $7.63
  • Average True Range (ATR)
  • BCYC 0.48
  • LXU 0.25
  • MACD
  • BCYC 0.02
  • LXU 0.02
  • Stochastic Oscillator
  • BCYC 33.33
  • LXU 87.93

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: